Auxo Firm Directory · Independent Research Profile

Vance Street Capital

Vance Street Capital describes a platform-and-add-on investment model focused on medical technology, life sciences, industrial technology, and aerospace and defense. Its stated platform geography is the U.S. or Canada, while strategic add-ons may be located anywhere.

Key takeaway

What stands out about Vance Street Capital

Vance Street Capital publicly targets technology-driven B2B companies with engineered or technology-enabled products, mission-critical components, strong customer relationships, and strong brand equity. Typical platform criteria are $3M-$30M EBITDA and $30M-$350M enterprise value; strategic add-ons are identified as any size.[1][2][3][4][6][7][9][11][15]

What does Vance Street Capital invest in?

Vance Street Capital is a Los Angeles-based private equity firm focused on partnering with niche, market-leading businesses and transforming them into strategic assets. Its public materials describe a focus on technology-driven B2B companies in regulated end markets.

Vance Street states that more than 75% of its investments have been family-owned businesses and that it pursues less than 3% of opportunities evaluated. It announced that Fund IV closed at its $775 million hard cap in April 2024 and that total capital dedicated to the lower middle market exceeded $2 billion including Fund IV.[1][3][6]

Vance Street describes recapitalizations of family businesses, management buyouts, corporate carve-outs, industry consolidations, capital investment for strategic growth, and strategic add-on acquisitions as typical investment scenarios.

The firm also describes transition options that include a full transition at closing, a partial transition with continued seller involvement, or continued full engagement by the seller in a desired operating position.[4]

Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.

Public size / criteria information
Typical platform criteria are $3M-$30M EBITDA and $30M-$350M enterprise value. Strategic add-on acquisitions are identified as any size. Vance Street announced that Fund IV closed at its $775 million hard cap in April 2024 and that total capital dedicated to the lower middle market exceeded $2 billion including Fund IV.[4][6]

What should a business owner evaluate before considering a transaction with Vance Street Capital?

Owners evaluating Vance Street should clarify how a proposed transaction would use the firm’s stated full-transition, partial-transition, or continued operating-role structures. They should also establish the expected equity rollover or retained ownership, governance and reserved-matter rights, ownership duration and exit framework, contemplated leverage, and the operating resources assigned to the company.

For a platform investment, owners should ask how any add-on acquisition strategy, integration expectations, and geographic expansion plans would apply to the business. The public materials describe add-on acquisition and seller-transition concepts but do not establish standardized terms for each situation.[4]

01

What percentage of equity rollover or retained ownership is typically expected

Public announcements identify retained or reinvested ownership in certain transactions, but the cited materials do not establish a standard percentage for sellers.[9][11]
02

What governance and reserved-matter rights would the seller and management team retain

Vance Street describes different seller-transition options, including continued involvement, but the cited strategy page does not specify governance or reserved-matter terms.[4]
03

What is the expected ownership duration and exit framework for a new platform investment

The official strategy page does not state a universal investment holding period or exit-timing schedule.[4]

What companies does Vance Street Capital target?

Vance Street states that it looks for businesses with engineered or technology-enabled products, deeply rooted customer relationships, mission-critical components, and strong brand equity.

Typical platform criteria are $3M-$30M EBITDA and $30M-$350M enterprise value. Strategic add-on acquisitions are identified as any size.[4]

The firm’s stated sectors are medical technology, industrial technology, life sciences, and aerospace and defense. Across these sectors, Vance Street seeks technology-driven B2B companies in regulated end markets differentiated by strong intellectual property, niche manufacturing capabilities, operational know-how, or high barriers to entry.[3][4]

Typical platform investments target businesses in the U.S. or Canada. Strategic add-on acquisitions may be located anywhere.[4]

Vance Street uses a platform-and-add-on model. Platform investments are subject to stated criteria of $3M-$30M EBITDA and $30M-$350M enterprise value, while strategic add-on acquisitions are identified as any size and may be located anywhere.

Recent public examples include the announced acquisition of Injectech and formation of the VSC Medical Molding platform, with Plastic Design Company and Resenex also identified as part of that platform. Vance Street’s portfolio company Keltec Technolab also announced its acquisition of Swift Filters.[4][10][12]

Vance Street’s official portfolio page lists Applied Plastics, Damotech, Excel Scientific, Fumex Air Filtration Systems, Jet Parts Engineering, Keltec Technolab, Micronics Engineered Filtration, Motion Dynamics, Prince, Pro-Vision, System Seals, Terra Insights, VS Aviation, and Wytech.[5]

Recent official announcements include a partnership with Pro-Vision dated September 26, 2024; a partnership with Prince Sterilization Services dated November 6, 2024; a partnership with System Seals dated December 9, 2024; Keltec Technolab’s announced acquisition of Swift Filters dated September 9, 2025; a partnership with Damotech dated November 13, 2025; and the announced acquisition of Injectech and formation of the VSC Medical Molding platform dated November 18, 2025.

Vance Street announced a binding agreement dated January 16, 2026, to sell Jet Parts Engineering and Victor Sierra Aviation Holdings to TransDigm for $2.2 billion.[7][8][9][10][11][12][13]

What is not clear from Vance Street Capital's public investment criteria?

The official Pro-Vision, System Seals, Keltec, and Damotech transaction announcements state that the terms of those transactions were not disclosed.

The official strategy page does not state a universal investment holding period or exit-timing schedule; it describes transaction structures and seller-transition options instead.[4][7][9][11][15]

Questions to ask when evaluating Vance Street Capital as a buyer or investment partner

What percentage of equity rollover or retained ownership is typically expected?
Public announcements identify retained or reinvested ownership in certain transactions, but the cited materials do not establish a standard percentage for sellers.[9][11]
What governance and reserved-matter rights would the seller and management team retain?
Vance Street describes different seller-transition options, including continued involvement, but the cited strategy page does not specify governance or reserved-matter terms.[4]
What is the expected ownership duration and exit framework for a new platform investment?
The official strategy page does not state a universal investment holding period or exit-timing schedule.[4]
How much leverage is contemplated?
The cited public materials describe investment criteria and transaction structures but do not establish leverage for a proposed transaction.[4]
Which operating partners and resources would be dedicated to the company?
Vance Street describes strategic growth capital and seller-transition structures, making the specific operating resources for a proposed investment a point to clarify.[4]
What add-on acquisition strategy, integration expectations, and geographic expansion plans apply?
The firm publicly describes strategic add-on acquisitions, including acquisitions that may be located anywhere, but the cited materials do not establish the plan for a particular platform.[4][12]
Which transaction terms are negotiable for a full versus partial transition?
Vance Street publicly describes full-transition and partial-transition options, while specific transaction terms are not standardized in the cited materials.[4][7][9][11][15]

Sources & research notes

Public-source research
  1. Official website / firm overview
  2. Official website / firm overview
  3. Investment strategy
  4. Industry / market focus
  5. Transaction / portfolio evidence
  6. Transaction size / criteria
  7. Transaction / portfolio evidence
  8. Transaction / portfolio evidence
  9. Transaction / portfolio evidence
  10. Transaction / portfolio evidence
  11. Transaction / portfolio evidence
  12. Transaction / portfolio evidence
  13. Transaction / portfolio evidence
  14. SEC investment adviser record
  15. Public disclosure information
Prepared and reviewed by: Auxo Capital AdvisorsEvidence standard: Public-source verification

How this profile was researched

Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.

Independent profile & regulatory context

Independent research profile

This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.

Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.

Broker-dealer and securities disclosure

Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.

Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.

Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.

Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.